Ingredient

Perfluorodecalin

Perfluorodecalin is flagged for pregnancy, breastfeeding, trying to conceive, PCOS, postpartum and general use. The concern behind the strongest flag is absorbed into the body and fetal development.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
6 of 6
Counting avoid, high risk and medium risk
Irritancy
1 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Perfluorodecalin and pregnancy

Not Recommended

Perfluorodecalin belongs to the perfluorinated compounds (PFCs) family, synthetic chemicals used as solvents in cosmetics. These compounds are highly stable, fat-soluble molecules that can persist in the body and cross the placental barrier. Studies on related PFCs show concerning effects on pregnancy outcomes. Research published in environmental health journals has linked prenatal PFC exposure to reduced birth weight, preeclampsia risk, and altered thyroid hormone levels in pregnant women. According to the CDC, PFCs have been detected in umbilical cord blood, demonstrating fetal exposure. While specific data on perfluorodecalin in topical products is limited, the chemical structure and fat-solubility raise concerns about bioaccumulation during pregnancy. Most obstetricians and dermatologists recommend avoiding perfluorinated compounds during pregnancy as a precautionary measure, especially given their environmental persistence and potential for bioaccumulation. The American College of Obstetricians and Gynecologists (ACOG) acknowledges PFCs as chemicals of concern for reproductive health. Many pregnant women choose to avoid products containing PFCs until more safety data becomes available.

BreastfeedingAVOID

Perfluorodecalin and breastfeeding

Not Recommended

Perfluorodecalin is a fat-soluble perfluorinated compound, and PFCs are known to transfer into breast milk. Studies have consistently detected various PFCs in breast milk samples worldwide, with concentrations correlating to maternal exposure levels. Research published in environmental health perspectives shows that breastfed infants can have higher PFC blood levels than their mothers due to concentration in milk fat. The half-life of PFCs in the body is extremely long (years), meaning any absorbed compound persists and continues to transfer to milk over extended periods. While specific toxicity data for perfluorodecalin in infants is lacking, related PFCs have shown immunosuppressive effects in animal studies. The AAD and lactation consultants generally recommend avoiding perfluorinated compounds during breastfeeding due to documented milk transfer and potential infant exposure. Given the lack of essential benefit from this cosmetic ingredient and the known persistence of PFCs, most healthcare providers suggest choosing PFC-free products while breastfeeding.

PostpartumCAUTION

Perfluorodecalin and postpartum

Caution Advised

For postpartum women not breastfeeding, perfluorodecalin carries moderate concerns related to hormonal recovery and long-term bioaccumulation. The postpartum period involves significant hormonal rebalancing, and PFCs have demonstrated endocrine-disrupting properties in research studies. While there's no direct milk transfer concern, PFCs that accumulate in maternal tissue during the postpartum period could affect future pregnancies or breastfeeding attempts. Given the years-long persistence of these compounds in the body, dermatologists often recommend avoiding PFCs during the reproductive years to minimize bioaccumulation before potential future pregnancies.

Trying to ConceiveAVOID

Perfluorodecalin and trying to conceive

Not Recommended

For women trying to conceive, perfluorodecalin poses concerns due to its fat-solubility, long biological half-life, and potential endocrine-disrupting properties. Research on related PFCs has shown associations with longer time to pregnancy and reduced fertility in some studies. Since PFCs persist in the body for years and cross the placental barrier, any accumulation during the TTC period will continue into early pregnancy. Reproductive endocrinologists recommend minimizing PFC exposure before conception to reduce fetal exposure during critical early developmental windows. Starting a PFC-free routine before becoming pregnant is considered prudent planning.

PCOSAVOID

Perfluorodecalin and PCOS

Not Recommended

Perfluorodecalin is a perfluorinated compound that may interfere with endocrine function. For women with PCOS, who already experience hormonal imbalances affecting androgens, insulin, and reproductive hormones, exposure to potential endocrine disruptors is particularly concerning. Research on PFCs has shown associations with altered thyroid function, insulin resistance, and reproductive hormone disruption—all systems already compromised in PCOS. A study in Human Reproduction found correlations between PFC exposure and irregular menstrual cycles. While direct studies on perfluorodecalin and PCOS are lacking, the chemical class raises concerns. Endocrinologists and dermatologists treating PCOS patients often recommend minimizing exposure to known or suspected endocrine disruptors. Given that perfluorodecalin offers no therapeutic benefit for PCOS symptoms and belongs to a concerning chemical class, most specialists suggest avoiding it in favor of hormonally-neutral alternatives.

General UseCAUTION

Perfluorodecalin and general use

Caution Advised

Perfluorodecalin is a synthetic solvent from the perfluorinated compound (PFC) family used in cosmetics for its unique properties. It's stable, inert on the skin surface, and can carry oxygen, making it useful in certain formulations. The primary concern with PFCs is their environmental persistence and bioaccumulation potential. These compounds don't break down naturally and have been found in water supplies, wildlife, and human blood worldwide. Studies suggest that PFCs may interfere with thyroid function, immune response, and cholesterol metabolism. The topical absorption rate of perfluorodecalin specifically is not well characterized, but related PFCs are known to be absorbed through skin. Environmental and health organizations increasingly recommend avoiding PFCs when possible. The EPA lists them as emerging contaminants, and the EU is progressively restricting their use. While a single application is unlikely to cause acute harm, the concern centers on chronic low-level exposure and the decades-long persistence of these chemicals in human tissue. Many consumers and dermatologists are choosing PFC-free alternatives as a precautionary approach.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Perfluorodecalin, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store